• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16861 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     Agency for Healthcare Research and Quality (AHRQ) Decisional dilemmas in discontinuing prolonged disease-modifying treatment for multiple sclerosis
2015     HAYES, Inc. Magnetic sphincter augmentation (LINX Reflux Management System) for treatment of gastroesophageal reflux disease
2015     NIHR Horizon Scanning Centre (NIHR HSC) Natalizumab (Tysabri) for secondary progressive multiple sclerosis
2015     The Regional Health Technology Assessment Centre (HTA-centrum) Chlorhexidine wash prior to clean surgical procedures
2015     NIHR Health Technology Assessment programme A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)
2015     NIHR Health Technology Assessment programme Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold
2015     Agency for Healthcare Research and Quality (AHRQ) Treatments for ankyloglossia and ankyloglossia with concomitant lip-tie
2015     HAYES, Inc. Nivolumab (Opdivo) for first-line treatment of advanced melanoma
2015     NIHR Horizon Scanning Centre (NIHR HSC) Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy
2015     NIHR Health Technology Assessment programme Saline in Acute Bronchiolitis RCT and Economic evaluation: hypertonic saline in acute bronchiolitis - randomised controlled trial and systematic review
2015     NIHR Health Technology Assessment programme Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation
2015     NIHR Health Services and Delivery Research programme Right cot, right place, right time: improving the design and organisation of neonatal care networks – a computer simulation study
2015     HAYES, Inc. Physical therapy for chronic pelvic pain
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (Brilique) for preventing thombotic events in patients with acute ischaemic stroke or high risk transient ischaemic attack
2015     The Regional Health Technology Assessment Centre (HTA-centrum) Home mechanical ventilator treatment for chronic obstructive pulmonary disease patients with chronic hypercapnia
2015     NIHR Health Technology Assessment programme A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding
2015     NIHR Health Technology Assessment programme INVESTIGATE-I (INVasive Evaluation before Surgical Treatment of Incontinence Gives Added Therapeutic Effect?): a mixed-methods study to assess the feasibility of a future randomised controlled trial of invasive urodynamic testing prior to surgery for stress urinary incontinence in women
2015     NIHR Health Services and Delivery Research programme Patient safety in ambulance services: a scoping review
2015     HAYES, Inc. Rolapitant (Varubi) in combination with other antiemetic drugs to prevent delayed nausea and vomiting from cancer chemotherapy
2015     NIHR Horizon Scanning Centre (NIHR HSC) APN311 for high risk neuroblastoma in children and adolescents – first line
2015     NIHR Health Technology Assessment programme Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation
2015     NIHR Health Services and Delivery Research programme An evidence synthesis of risk identification, assessment and management for young people using tier 4 inpatient child and adolescent mental health services
2015     HAYES, Inc. Use of anti-infliximab antibody levels to monitor infliximab treatment in patients with inflammatory bowel disease (IBD)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Atezolizumab for urothelial bladder cancer – second and subsequent line
2015     NIHR Public Health Research (PHR) programme Football Fans in Training (FFIT): a randomised controlled trial of a gender-sensitised weight loss and healthy living programme for men - end of study report
2015     NIHR Health Services and Delivery Research programme A qualitative and quantitative evaluation of the Advancing Quality pay-for-performance programme in the NHS North West
2015     HAYES, Inc. Wireless pulmonary artery pressure monitoring with CardioMEMS HF System (St. Jude Medical) for management of chronic heart failure
2015     NIHR Horizon Scanning Centre (NIHR HSC) Brentuximab vedotin (Adcetris) for CD30-positive cutaneous T-cell lymphoma
2015     NIHR Public Health Research (PHR) programme Can community-based peer support promote health literacy and reduce inequalities? A realist review
2015     NIHR Health Services and Delivery Research programme What is the evidence on interventions to manage referral from primary to specialist non-emergency care? A systematic review and logic model synthesis
2015     NIHR Health Technology Assessment programme The London Exercise And Pregnant smokers (LEAP) trial: a randomised controlled trial of physical activity for smoking cessation in pregnancy with an economic evaluation
2015     HAYES, Inc. Zio patch (iRhythm Technologies Inc.) for long-term ambulatory cardiac rhythm monitoring
2015     NIHR Horizon Scanning Centre (NIHR HSC) Buparlisib in combination with fulvestrant for hormone-receptor positive/HER2-negative locally advanced or metastatic breast cancer
2015     NIHR Health Technology Assessment programme Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock
2015     NIHR Health Services and Delivery Research programme Translation into British Sign Language and validation of the Strengths and Difficulties Questionnaire
2015     NIHR Health Services and Delivery Research programme Delivering the aims of the Collaborations for Leadership in Applied Health Research and Care: understanding their strategies and contributions
2015     Agency for Healthcare Research and Quality (AHRQ) Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force
2015     HAYES, Inc. CancerTYPE ID
2015     NIHR Horizon Scanning Centre (NIHR HSC) Cabozantinib (Cometriq) for metastatic renal cell carcinoma –second line
2015     NIHR Health Technology Assessment programme Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure
2015     NIHR Health Services and Delivery Research programme Evaluating a major innovation in hospital design: workforce implications and impact on patient and staff experiences of all single room hospital accommodation
2015     Agency for Healthcare Research and Quality (AHRQ) Aspirin use for the prevention of colorectal cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force
2015     HAYES, Inc. ConfirmMDx for prostate cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Elotuzumab with lenalidomide for multiple myeloma – first line
2015     NIHR Health Technology Assessment programme The London Exercise And Pregnant smokers (LEAP) trial: a randomised controlled trial of physical activity for smoking cessation in pregnancy with an economic evaluation
2015     NIHR Health Services and Delivery Research programme Improving practice in safeguarding at the interface between hospital services and children's social care: a mixed-methods case study
2015     Agency for Healthcare Research and Quality (AHRQ) Aspirin use in adults: cancer, all cause mortality, and harms. A systematic evidence review for the U.S. Preventive Services Task Force
2015     HAYES, Inc. know error DNA Specimen Provenance Assay (Strand Diagnostics)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Neratinib with capecitabine for advanced or metastatic HER2-positive breast cancer – third line
2015     NIHR Health Services and Delivery Research programme Improving community health networks for people with severe mental illness: a case study investigation
2015     Belgian Health Care Knowledge Centre (KCE) What are the recommended clinical assessment and screening tests during pregnancy?
2015     Agency for Healthcare Research and Quality (AHRQ) Aspirin use to prevent cardiovascular disease and cancer: a decision analysis
2015     HAYES, Inc. Oncotype DX Colon Cancer Assay
2015     NIHR Horizon Scanning Centre (NIHR HSC) Palbociclib for advanced or metastatic, oestrogen-receptor positive, HER2-negative, recurrent breast cancer – second line
2015     Belgian Health Care Knowledge Centre (KCE) Bladder cancer: an assessment of international practice guidelines
2015     Agency for Healthcare Research and Quality (AHRQ) Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force
2015     HAYES, Inc. Prosigna Breast Cancer Prognostic Gene Signature Assay
2015     Belgian Health Care Knowledge Centre (KCE) Comprehensive geriatric care in hospitals: the role of inpatient geriatric consultation teams
2015     Agency for Healthcare Research and Quality (AHRQ) Psychosocial and pharmacologic interventions for disruptive behavior in children and adolescents
2015     HAYES, Inc. Tissue of Origin Test (ResponseDX)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vandetanib (Caprelsa) for locally advanced or metastatic differentiated thyroid cancer – second line
2015     Belgian Health Care Knowledge Centre (KCE) Oncogenetic testing for persons with hereditary endocrine cancer syndromes
2015     Agency for Healthcare Research and Quality (AHRQ) Behavioral programs for diabetes mellitus
2015     HAYES, Inc. Autologous stem cell therapy for treatment of avascular necrosis of the hip
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vemurafenib (Zelboraf) for metastatic BRAF V600 mutation positive melanoma in children and adolescents
2015     Belgian Health Care Knowledge Centre (KCE) Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2.
2015     Agency for Healthcare Research and Quality (AHRQ) Screening for speech and language delays and disorders in children age 5 years or younger: a systematic review for the U.S. Preventive Services Task Force
2015     HAYES, Inc. Cryoablation for treatment of non-small cell lung cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) GS-6615 for long QT-3 syndrome
2015     Belgian Health Care Knowledge Centre (KCE) Gene expression profiling and immunohistochemistry tests for personalised management of adjuvant chemotherapy decisions in early breast cancer – a Rapid Assessment
2015     HAYES, Inc. Full-field digital mammography for breast cancer screening
2015     NIHR Horizon Scanning Centre (NIHR HSC) Holoclar for the treatment of limbal stem cell deficiency due to ocular burns
2015     Technology Assessment at SickKids (TASK) A cost-effectiveness analysis of maternal genotyping to guide treatment for postpartum pain and avert infant adverse events
2015     Belgian Health Care Knowledge Centre (KCE) Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, LiFraumeni syndrome and Cowden syndrome
2015     Medical Services Advisory Committee (MSAC) The use of Intensity Modulated Radiation Therapy (IMRT) in the treatment of cancer
2015     HAYES, Inc. Intraoperative radiotherapy for treatment of early-stage breast cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Midodrine (Bramox) for orthostatic hypotension
2015     NIHR Health Technology Assessment programme The cost-effectiveness of domiciliary non-invasive ventilation in patients with end-stage chronic obstructive pulmonary disease: a systematic review and economic evaluation
2015     Medical Services Advisory Committee (MSAC) The use of Image Guided Radiation Therapy (IGRT) in the treatment of cancer
2015     HAYES, Inc. Metal-on-metal hip resurfacing arthroplasty versus total hip replacement for osteoarthritis
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tenofovir alafenamide monotherapy for hepatitis B
2015     NIHR Public Health Research (PHR) programme Preventing domestic abuse for children and young people (PEACH): a mixed knowledge scoping review
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Riociguat (Adempas®)
2015     HAYES, Inc. MRI-TRUS fusion-guided biopsy for the diagnosis of prostate cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Baricitinib for moderate to severe rheumatoid arthritis
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rituximab (MabThera®)
2015     NIHR Health Services and Delivery Research programme Mobilising knowledge to improve UK health care: learning from other countries and other sectors – a multimethod mapping study
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Lisdexamfetamine dimesylate (Elvanse Adult®)
2015     HAYES, Inc. K9 inhibitors for cholesterol reduction: alirocumab and bococizumab
2015     NIHR Horizon Scanning Centre (NIHR HSC) Certolizumab (Cimzia) for early rheumatoid arthritis – first line
2015     NIHR Health Technology Assessment programme A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ponatinib (Iclusig®)
2015     NIHR Health Services and Delivery Research programme Contracting with General Dental Services: a mixed-methods study on factors influencing responses to contracts in English general dental practice
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Riociguat (Adempas®)
2015     HAYES, Inc. Peroral Endoscopic Myotomy (POEM) for treatment of esophageal achalasia
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for psoriatic arthritis – second or subsequent line
2015     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of telephone triage for managing same-day consultation requests in general practice: a cluster randomised controlled trial comparing general practitioner-led and nurse-led management systems with usual care (the ESTEEM trial)
2015     NIHR Health Technology Assessment programme Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Umeclidinium (Incruse®)
2015     NIHR Health Services and Delivery Research programme The organisation and delivery of health improvement in general practice and primary care: a scoping study